Researchers from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) reported that posttransplant cyclophosphamide (PTCy)-based GVHD pro...

Concurrent chemotherapy with radiation therapy did not significantly increase the cumulative incidence of second pelvic malignancies, though it did in...

The FDA has granted breakthrough therapy designation to zongertinib tablets (Hernexeos) as first-line treatment for patients with unresectable or meta...

The 2025 IASLC World Conference on Lung Cancer (WCLC) is right around the corner, and CancerNetwork® has put its social listening skills to the test....

Circulating tumor DNA (ctDNA) has rapidly evolved into a valuable prognostic tool in colorectal cancer management, particularly after surgical resecti...

The patient demonstrated an excellent response to CAR T therapy, achieving complete remission with MRD-negative status, representing the deepest possi...

The future of multiple myeloma treatment is rapidly evolving with several groundbreaking immunotherapy approaches in development. Beyond current CAR T...

In the postoperative period following colorectal cancer surgery, effective communication of pathology results and risk assessment for recurrence are c...

Chronic myeloid leukemia (CML) was once known as a deadly disease, renowned for its difficulty to treat. Now, therapies exist such that, following ini...

The FDA has approved denosumab-nxxp as a 60 mg/mL injection (Bildyos) and denosumab-nxxp as a 120 mg/1.7 mL injection (Bilprevda) as biosimilars to de...